echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Deloitte 2016 global health industry report, what factors affect medical control?

    Deloitte 2016 global health industry report, what factors affect medical control?

    • Last Update: 2016-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: arteria.com.2016-01-22 global medical and health fields, including medical service providers, payers, governments and other stakeholders, are actively improving medical services by efficient, fair and reasonable means The spread of chronic diseases and the aging population are the main causes of the change According to the report of the Department of economic information (EIU), the expenditure on health care in 60 countries increased by an average of 2.6% in US dollars in 2014 At the same time, a report of the World Health Organization (who) pointed out that there were significant differences in the expenditure on health care between developed and developing countries As can be seen in Figure 1, China's per capita medical expenditure in 2013 was $367, a significant gap from the US $9146 Global healthcare spending is expected to grow by four percentage points in 2016, with an average of more than 6% in 2017 and 2018, especially in Asia and the Middle East, where private or public healthcare spending will continue to rise However, the reality is contradictory We should not only control the cost but also improve the service level Therefore, the EIU predicts that the global medical and health expenditure will increase only 4.3% on average from 2015 to 2019, and the proportion of the total GPD will decrease from 10.3% in 2015 to 10.1% in 2019 Looking at the major factors affecting the global healthcare industry in 2016, they are population, economy, operation, innovation and institutional regulation As shown in Figure 2 Although the increase of medical expenses is closely related to the increase of administrative expenses, insurance premiums and nursing costs, on the other hand, the adoption of new medical technology and innovative means will also lead to the increase of medical costs However, the future development path is clear, and relevant departments must seek new ways to reduce costs Analysis of factors affecting medical cost 1 The trend of integration of medical institutions; the medical industry is changing from fragmented and decentralized model to integration and connection In some countries, the increasingly fierce competition and rising costs will present an evolutionary pattern of "the larger the scale, the better" The merger and acquisition of medical institutions and the alliance and independence of doctor groups not only conform to the trend of economic expansion, but also can effectively resist the pressure of upper level supervision Improving the transparency of medical process, increasing the quality of care and improving the medical results are required by the regulatory authorities, and the medical mode decided by individuals will gradually be replaced by standardized guidance and policy provisions Finally, the popularization of communication technology will connect the whole world, and the public's expectation for the medical industry will be higher and higher 2 medical institutions pursuing population health and responsible for health management realize that it is more necessary to predict people's disease risks in advance Medical institutions and social health care system should work together to transform public and private sectors from disease treatment to medical prevention, so as to optimize medical outcomes Although there have been good signs in the UK, Mexico, Japan and Germany, on the whole, preventive medicine is still in its early stage 3 The most famous change of the price rating standard is that the United States advocates the medical reform from the FFS mode of paying by service items to the VBS mode of paying by service results The current situation is that some institutions are actively preparing for the VBC mode, while others are still holding a wait-and-see attitude The behavior of slow-moving medical institutions is understandable, because the VBS model has huge investment, and the FFS payment model has considerable profits, and the stakeholders have not made clear and reasonable rigid regulations on medical value judgment Therefore, when the medical expenses and the number of patients increase simultaneously, stakeholders need to find ways to deal with them at a lower cost The reality is that many obstacles are blocking the goal VBC medical and health system is speeding up capital turnover and improving service by optimizing supply chain For example, batch purchasing, improving records management, reducing labor costs and improving clinical medical efficiency can improve profits in the short term, but they are not the most essential solution Looking forward, the health care system will pay more attention to the existing financial business model, and will pay attention to the actual medical value of each dollar Figure 3 shows the transition of VBC payment mode from FFS, sharing saving, binding payment, risk sharing to cost sharing From low-level to high-level, medical institutions bear more and more responsibility for fee control and payment risk Therefore, in order to reconstruct the VBC model, medical institutions need to invest in the following aspects: 1 Evaluate the medical performance: adopt reporting and analysis tools to measure the results; 2 Involve patients: use tools to improve patients' medical knowledge and ability, and increase treatment compliance; 3 Medical collaboration: medical service providers timely participate in management to reduce costs and improve quality; 4 risk sharing: hierarchical management and control of disease risks caused by clinical or patients' living habits; 5 medical plan: develop a new medical path based on evidence-based medicine to continuously manage diseases As shown in Figure 4: Figure 4 5 PPP mode PPP mode will build infrastructure, jointly develop technology and participate in operation and management activities PPP model can help the government to provide more medical services, expand medical coverage and solve the cost burden Some PPP models include risk classification, similar to VBC model, in which the government will give financial incentives to private institutions based on medical results PPP model will give birth to a more efficient medical operation system, and the patient-centered medical model is the most obvious change From the isolated medical treatment of a single department to the integrated comprehensive medical treatment of multiple departments, from the breakpoint segmented medical treatment to the continuous disease monitoring medical treatment, from the doctor as the main body to the patient-centered medical treatment, from the individual doctor's medical service to the multi-disciplinary mixed group diagnosis medical treatment, from one-sided local medical management to the joint management and care of patients with external cooperation The Deloitte report also points out that for China's second and third tier cities, even though the Chinese government has invested a lot of money in hospitals, basic medical services still need to be strengthened These cities need trained doctors, doctors who are good at disease diagnosis and other medical practitioners to maximize the benefits of mobile medical technology investment and infrastructure investment Figure 6 shows the relative ratio of beds per thousand to local population worldwide in 2014 and 2019 In addition, the improvement of the medical industry in various countries also includes the reorganization of administrative functions, information sharing and openness, reduction of duplicate medical testing services, bold use of digital technology, reduction of the dependence on opposite medical treatment, and promotion of home-based care and self-health management of patients Many countries, such as Canada, the United Kingdom and Australia, have different independent medical and health institutions, from primary to secondary, tertiary, clinical training, leadership development, quality standard setting, testing, supervision to decision-making institutions There are different service administrative departments, which perform their own tasks It is expected that in 2016, many medical and health institutions will strive to reduce unit costs and implement shared services In addition, according to RAND research, 31% of the medical expenses in the United States are incurred in hospitals Improving the hospital medical coordination process is of great benefit to reducing medical waste and promoting the development of the entire medical industry Cost pressure, changes in staffing patterns, technological advances and consumer preferences all create "everywhere" new healthcare Accordingly, many medical and health systems are introducing a variety of alternative medical service modes, such as decentralization from national control to local management, from large hospitals to lower cost infrastructure applications According to statistics, on average, from 2014 to 2017, the proportion of every 1000 doctors and the world's population remained basically unchanged India was the one with the most doctors in short supply, and the proportion of doctors and population was 0.6:1, while China was also not optimistic The multi-point practice of hospitals has not been opened, which has hindered the development of private hospitals Although there are many pilot projects of practicing in some areas, the public still care about the ranking and brand influence of public hospitals, and private hospitals and foreign hospitals are more difficult to recruit doctors with high reputation In the face of intensified market competition and continuous regulatory pressure, most medical institutions in the United States take the form of merger and integration of hospitals to provide large-scale health system and a wider range of services In 2014 and mid-2015, the growth of M & A of medical investment among medical institutions intensified, as shown in Figure 8: the M & A of medical institutions in the United States accounted for most of the M & A events in the first half of 2015 The emergence of human genome and precision medicine has opened up a new way to target the most challenging diseases However, the cost of medical innovation is also high For now, medical innovation will continue to drive up medical costs For example, new drugs approved in the United States for the treatment of hepatitis C will save the cost of liver failure and cancer treatment in the long run, but the unit price of drugs is still expensive For this reason, some states and commercial insurance companies actually limit the use of new drugs, which eventually leads to fierce competition between public and private organizations The government will also compare the application costs of new and old drugs, and comprehensively consider 2 The personalized precision medicine of precision medicine will change from the mass medicine of quality generalization in the past to the integrated diagnosis and disease management of drugs and equipment For example, the fy2016 budget of the U.S government proposed US $215 million for precision medicine, focusing on the construction of large-scale vertical extension research, and ensuring the sharing of patient data among many medical institutions and organizations under the legal framework Personal health care based on genetics will fundamentally improve the prognosis, for example, 30% - 40% of patients taking drugs have side effects However, precise treatment will help doctors develop more accurate treatment plans and reduce side effects 3 The future trend of digital connection of medical treatment is to get through the inside and outside of the hospital and realize the communication between doctors and patients anytime and anywhere Medical institutions will explore the mode of enhancing communication between doctors and patients, encourage patients to participate, and support the prevention and management of chronic diseases outside the hospital From the concept of mobile healthcare mHealth to connected healthcare The digital realization of communication, diagnosis, treatment and monitoring is inseparable from the progress of medical technology Wearable devices can capture data with the participation of mobile medical apps and social media For example, developing countries are seriously short of medical resources and infrastructure, especially in rural areas, so it is necessary to explore digital technology to improve basic medical services, so as to make up the gap with urban health system The global digital medical market includes wireless medical technology, EHR, EMR, mobile medical, telemedicine and others In 2013, the global market reached US $60.8 billion, which is expected to reach US $233.3 billion in 2020, with a compound annual growth rate of 21.2% Moreover, the development of digital medicine has led to the development of wireless devices, sensors and intelligent devices In 2014, the investment in digital healthcare exceeded 4 billion US dollars, and telemedicine was the fastest growing area, with a year-on-year growth of 3.15 times from 2013 to 2014 Examples include how wearable devices collect human health data, contact lenses monitor blood glucose, hearing devices enhance hearing, heart rate monitoring devices, wristbands monitor heart rate, blood pressure and heat, intelligent tablets monitor the physiological response to medication, insole sensors measure weight, body fat balance and temperature
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.